Your browser doesn't support javascript.
loading
CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.
Yamamoto, Yurie; Sugimoto, Atsushi; Maruo, Koji; Tsujio, Gen; Sera, Tomohiro; Kushiyama, Shuhei; Nishimura, Sadaaki; Kuroda, Kenji; Togano, Shingo; Eguchi, Shinpei; Tanaka, Ryota; Kimura, Kenjiro; Amano, Ryosuke; Ohira, Masaichi; Yashiro, Masakazu.
Affiliation
  • Yamamoto Y; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Sugimoto A; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Maruo K; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Tsujio G; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Sera T; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Kushiyama S; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Nishimura S; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Kuroda K; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Togano S; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Eguchi S; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Tanaka R; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Kimura K; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Amano R; Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Ohira M; Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Yashiro M; Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
PLoS One ; 17(4): e0266027, 2022.
Article in En | MEDLINE | ID: mdl-35377900

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma / Receptors, Interleukin-8B Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Duct Neoplasms / Cholangiocarcinoma / Receptors, Interleukin-8B Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Estados Unidos